IBC's conference on pulmonary hypertension: new understanding for therapeutic development.
The International Business Communications conference on 'Pulmonary Hypertension: New Understanding for Therapeutic Development' was held in San Diego, CA, USA. Approximately 100 basic scientists and clinicians from academia and industry participated in this highly interactive two-day symposium on pulmonary hypertension (PHT). Topics discussed included current clinical therapies and novel therapeutic strategies, e.g., nitric oxide, phosphodiesterase (PDE) inhibition, prostacyclin synthase expression, endothelin receptor antagonism and elastase inhibition.
ZENECA Pharmaceuticals, A business unit of ZENECA, INC., Wilmington, DE 19850-5437, USA. russell.bialecki@phwilm.zeneca.com
R A
RA
Bialecki